Back to Search
LARA RIIS, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1740343813Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
14578-040(WI)
Research & Publications (20)
Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept.
PMID 19370307·Clin Rheumatol·2009
5-case
Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and follow-up evaluation of malignancy and mortality.
PMID 18848503·Clin Gastroenterol Hepatol·2008
8-other
Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort.
PMID 17555460·Am J Gastroenterol·2007
8-other
Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease course.
PMID 17354113·Scand J Gastroenterol·2007
4-observational
Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel Disease.
PMID 17278126·Inflamm Bowel Dis·2007
4-observational
Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years.
PMID 17258717·Gastroenterology·2007
4-observational
Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.
PMID 17206705·Inflamm Bowel Dis·2007
8-other
The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients.
PMID 17206636·Inflamm Bowel Dis·2007
4-observational
Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis.
PMID 17028127·Gut·2007
4-observational
Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
PMID 17598963·Digestion·2007
4-observational
Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study.
PMID 16782622·Scand J Gastroenterol Suppl·2006
4-observational
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
PMID 16952541·Gastroenterology·2006
4-observational
Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease.
PMID 16863558·Am J Gastroenterol·2006
4-observational
Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
PMID 16771949·Am J Gastroenterol·2006
8-other
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
PMID 16481630·Gut·2006
8-other
Infliximab dependency in a national cohort of children with Crohn's disease.
PMID 16385252·J Pediatr Gastroenterol Nutr·2006
8-other
Phenotype at diagnosis predicts recurrence rates in Crohn's disease.
PMID 16361306·Gut·2006
4-observational
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort.
PMID 16150857·Gut·2006
4-observational
Intra- and interobserver variation in the use of the Vienna classification of Crohn's disease.
PMID 15973120·Inflamm Bowel Dis·2005
8-other
Genetic and environmental factors in monozygotic twins with Crohn's disease and their first-degree relatives: a case report.
PMID 16024933·Digestion·2005
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 301 RIVER STREET, PHARMACY
OSCEOLA, WI 54020 - Phone
- (715) 294-5624
Quick Facts
- NPI
- 1740343813
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile